SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Files 2014 Annual Report on Form 20-F The Company will provide a hard copy of its complete audited financial statements to its shareholders upon request, free of charge. Requests for a hard copy of the 2014 Annual Report can be made through the Contact IR page in the Investor Relations section of the Company's website by submitting complete mailing] []

By | 2016-03-16T06:37:39+00:00 April 29th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

PTR [PETROCHINA CO] 20-F: (Original Filing)

[x ¨ S-T ¨ ¨ non-accelerated 12b-2 x ¨ Non-Accelerated ¨ Large Accelerated Filer ¨ x ¨ ¨ ¨ 12b-2 ¨ x (APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PRECEDING FIVE YEARS) ¨ ¨ * ** Not for trading, but only in connection with the registration of American Depository Shares. *** **** Includes 889,085,900 H Shares represented] [Crude Oil Mutual Supply Framework Agreement for Year 2015 between PetroChina Company Limited and China Petrochemical Corporation January 2015 Crude Oil Mutual Supply Framework Agreement for Year 2015 PetroChina Company Limited (“PetroChina”) and China Petrochemical Corporation (“Sinopec”), following friendly consultations, have reached consensus on mutual supply of crude oil in the year of 2015 and hereby enter into this Agreement] [LIST OF SUBSIDIARIES A List of PetroChina Company Limited’s principal subsidiaries is provided in Note 19 to the consolidated financial statements included in this annual report following Item 19. EX-8.1 3 d913469dex81.htm EX-8.1] [CERTIFICATION I, Zhou Jiping, certify that: 1. I have reviewed this annual report on Form 20-F of PetroChina Company Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Yu Yibo, certify that: 1. I have reviewed this annual report on Form 20-F of PetroChina Company Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhou Jiping Chairman (performing the functions of Chief Executive Officer) EX-13.1 6 d913469dex131.htm EX-13.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yu Yibo Chief Financial Officer EX-13.2 7 d913469dex132.htm EX-13.2] [E OLYER AND AC AUGHTON D PRING ALLEY OAD 5001 S UITE AST S ALLAS EXAS D This is a digital representation of a DeGolyer and MacNaughton report. Each file contained herein is intended to be a manifestation of certain data in the subject report and as such is subject to the definitions, qualifications, explanations, conclusions, and other conditions thereof.] [THIRD PARTY REPORT RESERVES ESTIMATION AND EVALUATION OF CHAD, WEST QURNA AND KAZAKHSTAN ASSETS AS OF 31st DECEMBER, 2014 Prepared for PETROCHINA COMPANY LIMITED APRIL 2, 2015 CONFIDENTIAL Daniel R. Olds, RE. TBPE License No. 60996 Managing Senior Vice President RYDER SCOTT COMPANY, LR TBPE Firm Registration No. F-1580 Table of Contents Page No. INTRODUCTION 1 METHODOLOGY 1 1. RESULTS] [BRION ENERGY CORPORATION RESERVES ASSESSMENT AND EVALUATION OF CANADIAN OIL AND GAS PROPERTIES THIRD PARTY CORPORATE SUMMARY Effective December 31, 2014 1143014 THIRD PARTY CORPORATE SUMMARY TABLE OF CONTENTS Page COVERING LETTER 3 INDEPENDENT PETROLEUM CONSULTANTS’ CONSENT 5 INTRODUCTION 6 SUMMARY 8 EVALUATION PROCEDURE 12 PRODUCT PRICE AND MARKET FORECASTS 16 APPENDIX I Certificates of Qualification 17 Principal Officers: Keith]

By | 2016-03-20T06:58:30+00:00 April 29th, 2015|Categories: Chinese Stocks, PTR, SEC Original|Tags: , , , , , |0 Comments

QUNR [Qunar Cayman Islands] 6-K: (Original Filing)

[Qunar Announces Promotion of Senior Management Team and Files Annual Report BEIJING, April 29, 2015 (GLOBE NEWSWIRE) — Qunar Cayman Islands Limited (NASDAQ: QUNR) (“Qunar” or the “Company”), China’s leading mobile and online travel platform, today announced that its board of directors has appointed Ms. Yilu Zhao, previously Chief Strategy Officer of the Company, to Chief Financial Officer of the] [QUNAR CAYMAN ISLANDS LIMITED Sam Hanhui Sun]

MCOX [Mecox Lane] 20-F: (Original Filing)

[None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 455,227,428 ordinary shares, par value $0.0001 per share, as of December 31, 2014. o Yes x No o Yes x No x Yes o No x Yes] [THE COMPANIES LAW (2010 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF MECOX LANE LIMITED (adopted by a Special Resolution passed on October 1, 2010 and effective conditional and immediately upon completion of the Company’s initial public offering of ordinary shares represented by American Depositary Shares) (Conformed to include amendments] [January 1, 2015 1. Yili Wu 2. Mecox Lane E-commerce(Shanghai)Co.,Ltd Trademark License Agreement THIS AGREEMENT is made on January 1, 2015 BETWEEN: 1. Yili Wu (the “Licensor”); and 2. Mecox Lane E-commerce(Shanghai)Co., Ltd (the “Licensee”). WHEREAS the Licensor is the proprietor of the Trademark (as hereinafter defined) and is prepared to grant the Licensee and its affiliates a license to] [Share Sale and Purchase Agreement Relating to Giosis Mecoxlane Ltd. December 19 , 2014 Between Mecox Lane Limited (as Seller) and Oak Investment Partners XII, LP (as Buyer) This Share Sale and Purchase Agreement is made on December 19 , 2014 between: (1) Seller Mecox Lane Limited, an exempted company incorporated in the Cayman Islands with its registered office at] [EXECUTION VERSION August 8, 2014 FAST FASHION CHINA LIMITED (as Purchaser) and MECOX LANE LIMITED (as Seller) SHARE PURCHASE AGREEMENT related to MIXBLU LIMITED TABLE OF CONTENTS Clause Page 1. DEFINITIONS AND INTERPRETATION 3 2. SALE OF SHARES 8 3. CONSIDERATION 8] [Normal Building of Shanghai Chinalong Industrial Town Lease Contract Column A This contract is made by and between: Party A: Shanghai Chinalong Industrial Development Co., Ltd. Legal Address: 889 Yishan Road, Shanghai, China Tel: 64854680 64850557 Fax: 64854980 Business License: Party B: Mecox Lane E-commerce (Shanghai) Co., Ltd. Legal Address: Tel: Fax: Business License: Whereas, Party A has entered into] [Normal Building of Shanghai Chinalong Industrial Town Lease Contract Column A This contract is made by and between: Party A: Shanghai Chinalong Industrial Development Co., Ltd. Legal Address: 889 Yishan Road, Shanghai, China Tel: 64854680 64850557 Fax: 64854980 Business License: Party B: Mecox Lane E-commerce (Shanghai) Co., Ltd. Legal Address: Tel: Fax: Business License: Whereas, Party A has entered into] [Normal Plant of Lease Contract Party A: Shanghai Xindeli Financial Information Technology Co., Ltd Party B: Mecox Lane E-commerce ( Shanghai) Co., Ltd. Unit E on 9 Whereas, Party A is an owner of Premise at th Floor, Building 4,889 Yishan Road, Xuhui District, Shanghai , has obtained the legal, integral certificate of property right, and owns the Premise which] [Shanghai House Lease Contract (Contract No. ) Parties of this Contract: Lessor (Party A): Shanghai Xuanhua Architectural Ornament Co., Ltd Lessee (Party B): Mecox Lane E-commerce ( Shanghai) Co., Ltd. In accordance with the “Contract Law of the People’s Republic of China” and the “Regulations of the Shanghai Municipality on House Leasing” (hereinafter the “Regulations”), Party A and Party B,] [AGREEMENT ON TERMINATION Party A: Weiling Huang Party B: Shanghai Rampage Shopping Co., Ltd. Party C: Rampage Trading (Shanghai)Co., Ltd. WHEAERS, all parties have entered into the loan agreement, pledge agreement, purchase option agreement and related documents (Be known as “A Series of Agreements” hereinafter) Three parties have reached unanimity through friendly consultations, and entered into this Contract to terminate] [AGREEMENT ON TERMINATION Party A: Xiaobing Sang Party B: Shanghai Rampage Shopping Co., Ltd. Party C: Rampage Trading (Shanghai) Co., Ltd. WHEAERS, all parties have entered into the loan agreement, pledge agreement, purchase option agreement and related documents (Be known as “A Series of Agreements “ hereinafter) Three parties have reached unanimity through friendly consultations, and entered into this Contract] [AGREEMENT ON TERMINATION Party A: Guisheng Liu Party B: Shanghai Rampage Shopping Co., Ltd. Party C: Rampage Trading (Shanghai) Co., Ltd. WHEAERS, all parties have entered into the loan agreement, pledge agreement, purchase option agreement and related documents (Be known as “A Series of Agreements” hereinafter) Three parties have reached unanimity through friendly consultations, and entered into this Contract to] [List of Subsidiaries of Mecox Lane Limited Beneficially Owned Subsidiaries Name of Company Jurisdiction of Percentage of Attributable 1. eMecoxLane Co., Ltd Cayman Islands 100 % 2. Mexi-Care Limited Cayman Islands 100 % 3. Rampage China Limited Cayman Islands 80 % 4. Mecox Lane (Hong Kong) Limited Hong Kong 100] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER I, Ingrid Ye Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Mecox Lane Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER I, Guisheng Liu, certify that: 1. I have reviewed this annual report on Form 20-F of Mecox Lane Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Ingrid Ye Wang Chief Executive Officer 1 EX-13.1 16 a15-2911_1ex13d1.htm EX-13.1] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Guisheng Liu Acting Chief Financial Officer 1 EX-13.2 17 a15-2911_1ex13d2.htm EX-13.2] [Our ref RDS/611736-000001/8118658v1 Direct tel +852 2971 3046 Email richard.spooner@maplesandcalder.com Mecox Lane Limited Room 302, Qilai Building, No. 889 Yishan Road Shanghai 200233, People’s Republic of China 29 April 2015 Dear Sirs Mecox Lane Limited (the “Company”) Yours faithfully Maples and Calder EX-15.1 18 a15-2911_1ex15d1.htm EX-15.1] [25/F, Tower 3, Jing An Kerry Centre 1228 Middle Yan’an Road Shanghai 200040, P.R.C T: (86-21) 5298-5488 F: (86-21) 5298-5492 junhesh@junhe.com Mecox Lane Limited Room 302, QiLai Building, No. 889 Yishan Road Shanghai 200233 The People’s Republic of China Ladies and Gentlemen: Sincerely yours, For and on behalf of JUN HE LAW OFFICES Beijing Head Office Shenzhen Office Dalian Office] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in Registration Statement No.333-175359 on Form S-8 of our report dated April 29, 2015, relating to the consolidated financial statements and financial statement schedule of Mecox Lane Limited, appearing in the Annual Report on Form 20-F of Mecox Lane Limited for the year ended December 31,] [Giosis Mecoxlane Ltd. Consolidated Financial Statements As of and for the years ended December 31, 2014 and 2013 Giosis Mecoxlane Ltd. Index Table of Content Page(s) Independent Auditor’s Report 2 - 3 Consolidated Balance Sheet s 4 Consolidated Statement s of Comprehensive Loss 5 Consolidated Statement s of Changes in Equity 6 Consolidated Statement s of Cash Flows 7 Notes] [April 15, 2015 Mecox Lane Limited Room 302, QiLai Building, No. 889 Yishan Road People’s Republic of China Enclosed is our manually signed report relating to the use in Mecox Lane Limited ’s (“ Mecox Lane ”) Annual Report on Form 2 0- F our report dated April 15, 2015 , relating to the financial statements of Giosis Mecoxlane Ltd.]

CEO [CNOOC] 424B2: (Original Filing)

[PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED April 27, 2015 CNOOC FINANCE (2015) AUSTRALIA PTY LTD Australian Company Number 604 822 335 (incorporated in Victoria, Australia) US$1,500,000,000 2.625% Guaranteed Notes due 2020 US$300,000,000 4.200% Guaranteed Notes due 2045 unconditionally and irrevocably guaranteed by CNOOC Limited (incorporated with limited liability in Hong Kong) and CNOOC FINANCE (2015) U.S.A. LLC (formed in the State]

By | 2016-03-31T22:20:01+00:00 April 29th, 2015|Categories: CEO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

SVA [SINOVAC BIOTECH] 20-F: (Original Filing)

[None (Title of Class) Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 55,809,661 common shares as of December 31, 2014 o Yes x No o Yes x No x Yes o No x Yes o No Large accelerated filer] [List of Subsidiaries 1. Sinovac Biotech (Hong Kong) Ltd., a Hong Kong company 2. Tangshan Yian Biological Engineering Co., Ltd., a PRC company 3. Sinovac Biotech Co., Ltd., a PRC company 4. Sinovac Research and Development Co., Ltd. (formerly known as Beijing Sinovac Biological Technology Co., Ltd.), a PRC company 5. Sinovac (Dalian) Vaccine Technology Co., Ltd., a PRC company] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER I, Weidong Yin, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER I, Nan Wang, certify that: 1. I have reviewed this annual report on Form 20-F of Sinovac Biotech Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Weidong Yin Weidong Yin Chief Executive Officer EX-13.1 5 a14-26055_1ex13d1.htm EX-13.1] [CERTIFICATION BY THE CHIEF FINANCIAL OFFICER (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 29 , 2015 Nan Wang Chief Financial Officer EX-13.2 6 a14-26055_1ex13d2.htm EX-13.2] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-161827) pertaining to Sinovac Biotech Ltd.’s 2003 Stock Option Plan and the Registration Statement on Form S-8 (No. 333-190980) pertaining to Sinovac Biotech Ltd.’s 2012 Share Incentive Plan of our reports dated April 29, 2015, with respect to] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-161827) pertaining the Company’s 2003 Stock Option Plan and the Registration Statement on Form S-8 (No. 333-190980) pertaining to the Company’s 2012 Share Incentive Plan of our report dated April 29, 2013 with respect to the consolidated financial]

By | 2016-03-16T06:40:41+00:00 April 29th, 2015|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal HONG KONG, China, April 29, 2015 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal letter dated] [FORM 6-K CHINA CORD BLOOD CORPORATION 48 th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Yes o No x Other Events On April 2 9 Description]

By | 2016-03-27T09:12:42+00:00 April 29th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar